Heartflow, Inc. Research and Development Expense
Heartflow, Inc. (HTFL) reported Research and Development Expense of $26.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- Heartflow, Inc. research and development expense for the quarter ending 2026-06-30 was $26.26M, a 74.70% increase year-over-year.
- Heartflow, Inc. research and development expense for the quarter ending 2026-03-31 was $21.62M, a 55.27% increase year-over-year.
- Heartflow, Inc. research and development expense for the quarter ending 2025-12-31 was $18.66M, a 52.01% increase year-over-year.
- Heartflow, Inc. research and development expense for the quarter ending 2025-09-30 was $17.30M, a 45.81% increase year-over-year.
- Heartflow, Inc. research and development expense for fiscal 2025 was $64.92M, a 49.18% increase from fiscal 2024.
- Heartflow, Inc. research and development expense for fiscal 2024 was $43.52M, a 21.37% increase from fiscal 2023.
- Heartflow, Inc. research and development expense for fiscal 2023 was $35.85M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.26M 10-Q · filed 2026-08-13 | $47.88M 10-Q · filed 2026-08-13 | $66.55M derived: sum of 3 quarters · filed 2026-08-13 | $83.84M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $21.62M 10-Q · filed 2026-05-14 | $40.28M derived: sum of 2 quarters · filed 2026-05-14 | $57.58M derived: sum of 3 quarters · filed 2026-05-14 | $72.61M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $18.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $35.96M derived: sum of 2 quarters · filed 2026-03-18 | $50.99M derived: sum of 3 quarters · filed 2026-08-13 | $64.92M 10-K · filed 2026-03-18 |
| 2025-09-30 | $17.30M 10-Q · filed 2025-11-12 | $32.33M derived: sum of 2 quarters · filed 2026-08-13 | $46.25M 10-Q · filed 2025-11-12 | $58.53M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $15.03M 10-Q · filed 2026-08-13 | $28.96M 10-Q · filed 2026-08-13 | $41.23M derived: sum of 3 quarters · filed 2026-08-13 | $53.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $13.92M 10-Q · filed 2026-05-14 | $26.20M derived: sum of 2 quarters · filed 2026-05-14 | $38.07M derived: sum of 3 quarters · filed 2026-05-14 | $48.00M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $12.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $24.14M derived: sum of 2 quarters · filed 2026-03-18 | $34.07M derived: sum of 3 quarters · filed 2026-03-18 | $43.52M 10-K · filed 2026-03-18 |
| 2024-09-30 | $11.86M 10-Q · filed 2025-11-12 | $21.80M derived: sum of 2 quarters · filed 2025-11-12 | $31.24M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $9.93M 10-Q · filed 2025-09-19 | $19.38M 10-Q · filed 2025-09-19 | ||
| 2023-12-31 | $35.85M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |